We here hypothesised that both serum Nfs might serve as blood biomarkers of disease severity in both human SCA3 and mouse models, expecting increased concentrations at both the ataxic and preataxic stage, with increases in preataxic subjects occurring particularly in proximity to the onset of ataxia. This evidence concerns the gene ATXN3 and cerebellar ataxia.